Analysis of cycloserine and related compounds using aqueous normal phase chromatography/mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 64-65, Issue , 2012, Pages 72-76

  Pesek, Joseph J ^a   Matyska, Maria T ^a   Dang, Andy ^a  

^a SAN JOSE STATE UNIVERSITY   (United States)

Author keywords

Hydrophilic analytes; Pharmaceutical analysis; Silica hydride columns; Silica hydride stationary phase

Indexed keywords

ACETONITRILE; CYCLOSERINE; DIMER; FORMIC ACID; METHANOL; SILICON DIOXIDE; SOLVENT; WATER;

ANALYTIC METHOD; AQUEOUS NORMAL PHASE CHROMATOGRAPHY; ARTICLE; CHROMATOGRAPHY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILIC INTERACTION CHROMATOGRAPHY; HYDROPHILICITY; INSTRUMENT; LUNG TUBERCULOSIS; MASS SPECTROMETER; MASS SPECTROMETRY; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSERINE; DRUG CONTAMINATION; MASS SPECTROMETRY; REPRODUCIBILITY OF RESULTS; SILICATES; SOLVENTS;

EID: 84859264959     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.02.016     Document Type: Article

References (31)

1. Neuhaus F.C. Antibiotics I, Mechanism of Action, Springer 1967, 40-83. Verlag, New York. D. Gottlieb, P.D. Shaw (Eds.).
2. David S. Synergic activity of d-cycloserine and β-chloro-d-alanine against Mycobacterium tuberculosis. J. Antimicrob. Chemother. 2001, 47:203-206.
3. Kim Y.G., Lee Y.J., Lee E.D., Lee S.D., Kwon J.W., Kim W.B., Shim C.-K., Lee M.G. Bioequivalence assessment of closerin capsule to Dura seromycin capsule of cycloserine after a single oral dose administration to healthy male volunteers. Int. J. Clin. Pharmacol. Ther. 2000, 38:461-466.
4. Chung S., Johnson M.S., Gronenborn A.M. l-Cycloserine: a potent anticonvulsant. Epilepsia 1984, 25:353-362.
5. Scotto P., Monaco P., Scardi V., Bonavita V. Neurochemical studies with l-cycloserine, a central depressant agent. J. Neurochem. 1963, 10:831-839.
6. Wood J.D., Peesker S.J., Gorecki D.K.J., Tsui D. Effect of l-cycloserine on brain GABA metabolism. Can. J. Physiol. Pharmacol. 1978, 56:62-68.
7. Olson G.T., Fu M., Lau S., Rinehart K.L., Silverman R.B. An aromatization mechanism of inactivation of γ-aminobutyric acid aminotransferase for the antibiotic l-cycloserine. J. Am. Chem. Soc. 1998, 120:2256-2267.
8. Dann O.T., Carter C.E. Cycloserine inhibition of γ-aminobutyric-α-ketoglutaric transaminase. Biochem. Pharmacol. 1964, 13:677-684.
9. Soper T.S., Manning J.M. Different modes of action of inhibitors of bacterial d-amino acid transaminase. A target enzyme for the design of new antibacterial agents. J. Biol. Chem. 1981, 256:4263-4268.
10. Sundaram K.S., Lev M. Inhibition of sphingolipid synthesis by cycloserine in vitro and in vivo. J. Neurochem. 1984, 42:577-581.
11. Musson D.G., Maglietto S.M., Hwang S.S., Gravellese D., Bayne W.F. Simultaneous quantification of cycloserine and its prodrug acetylacetonylcycloserine in plasma and urine by high-performance liquid chromatography using ultraviolet absorbance and fluorescence after post-column derivatization. J. Chromatogr. B 1987, 414:121-129.
12. Burge L.J., Sorgen C.M. Evaluation of polar-embedded and polar-endcapped C12-C18 stationary phase vulnerabilities toward highly nucleophilic compounds: a case study. LC GC North Am. 2005, 8:762-765.
13. Pendala M., Dragovic S., Bockx L., Hoogmartens J., Van Schepdael A., Adams E. Development of a liquid chromatographic method for the determination of related substances and assay of d-cycloserine. J. Pharm. Biomed. Anal. 2008, 47:807-811.
14. Yoo G.S., Choi K., Stewart J.T. Second derivative ultraviolet spectrophotometry and high performance liquid chromatography with fluorometric detection of cycloserine using 9-chloro-10-methylacridinium triflate as a new UV and fluorescent labeling agent. Anal. Lett. 1990, 23:1245-1263.
15. David V., Ionescu M., Dumitrescu V. Determination of cycloserine in human plasma by high-performance liquid chromatography with fluorescence detection, using derivatization with p-benzoquinone. J. Chromatogr. B 2001, 761:27-33.
16. Karthikeyan K., Arularasu G.T., Ramadhas R., Pillai K., Chandrasekara K. Development and validation of indirect RP-HPLC method for enantiomeric purity determination of d-cycloserine drug substance. J. Pharm. Biomed. Anal. 2011, 54:850-854.
17. Pesek .J., Matyska M.T. Our favorite materials: silica hydride stationary phases. J. Sep. Sci. 2009, 32:3999-4011.
18. Pesek J.J., Matyska M.T., Fischer S.M., Sana T.R. Analysis of hydrophilic metabolites by high-performance liquid chromatography-mass spectrometry using a silica hydride-based stationary phase. J. Chromatogr. A 2008, 1204:48-55.
19. Pesek J.J., Matyska M.T. How to retain polar and nonpolar compounds on the same HPLC column with an isocratic mobile phase. LC/GC 2006, 24:296-303.
20. Pesek J.J., Matyska M.T., Larrabee S. HPLC retention behavior on hydride-based stationary phases. J. Sep. Sci. 2007, 30:637-647.
21. Pesek J.J., Matyska M.T. A Comparison of two separation modes: HILIC and aqueous normal phase chromatography. LCGC 2007, 25:480-490.
22. Pesek J.J., Matyska M.T., Hearn M.T.W., Boysen R.I. Aqueous normal-phase retention of nucleotides on silica hydride columns. J. Chromatogr. A 2009, 1216:1140-1146.
23. Pesek J.J., Matyska M.T., Duley J., Zamzami M., Fischer S.M. Aqueous normal phase (ANP) Retention of nucleotides on silica hydride-based columns. method development strategies for analytes relevant in clinical analysis. J. Sep. Sci. 2010, 33:930-938.
24. Boysen R.I., Yang Y., Chowdhury J., Matyska M.T., Pesek J.J., Hearn M.T.W. Simultaneous separation of hydrophobic and hydrophilic peptides with a silica hydride stationary phase using aqueous normal phase conditions. J. Chromatogr. A 2011, 1218:8021-8026.
25. Weisenberg S.A., Butterfield T.R., Fischer S.M., Rhee K.Y. Suitability of silica hydride stationary phase, aqueous normal phase chromatography for untargeted metabolomic profiling of Enterococcus faecium and Staphylococcus aureus. J. Sep. Sci. 2009, 32:2262-2265.
26. Callahan D.L., DeSouza D., Bacic A., Roessner U. Profiling of polar metabolites in biological extracts using diamond hydride-based aqueous normal phase chromatography. J. Sep. Sci. 2009, 32:2273-2280.
27. Pesek J.J., Matyska M.T., Loo J.A., Fischer S.M., Sana T.R. Analysis of hydrophilic metabolites in physiological fluids by HPLC-MS using a silica hydride-based stationary phase. J. Sep. Sci. 2009, 32:2200-2208.
28. Chu C.H., Jonsson E., Auvinen M., Pesek J.J., Sandoval J.E. A new approach for the preparation of a hydride-modified substrate used as an intermediate in the synthesis of surface-bonded materials. Anal. Chem. 1993, 65:808-816.
29. Hao Z., Xiao B., Weng N. Impact of column temperature and mobile phase components on selectivity of hydrophilic interaction chromatography (HILIC). J. Sep. Sci. 2008, 31:1449-1464.
30. Lammerhofer M., Richter M., Wu J., Nogueira R., Bicker W., Lindner W. Mixed-mode ion-exchangers and their comparative chromatographic characterization in reversed-phase and hydrophilic interaction chromatography elution modes. J. Sep. Sci. 2008, 31:2572-2588.
31. Wu J.Y., Bicker W., Lindner W. Separation properties of novel and commercial polar stationary phases in hydrophilic interaction and reversed-phase liquid chromatography mode. J. Sep. Sci. 2008, 31:1492-1503.